Given that mutations in KRAS/LKB1 or TP53 are known upstream drivers of CPS1 overexpression 11, 13, our finding that CPS1 overexpression promotes lung cancer metastasis can be considered as a functional consequence of these driver gene mutations. This evidence concerns the gene TP53 and lung carcinoma.